{"id":69421,"date":"2023-02-15T22:24:24","date_gmt":"2023-02-15T21:24:24","guid":{"rendered":"https:\/\/www.veeva.com\/eu\/?page_id=69421"},"modified":"2026-08-24T11:38:19","modified_gmt":"2026-08-24T09:38:19","slug":"heron-therapeutics-streamlines-clinical-trials-with-a-modern-ctms","status":"publish","type":"customer-stories","link":"https:\/\/pantheon.veeva.com\/eu\/customer-stories\/heron-therapeutics-streamlines-clinical-trials-with-a-modern-ctms\/","title":{"rendered":"Heron Therapeutics"},"content":{"rendered":"

\nRunning efficient clinical trials is essential for emerging
\nbiotechs to achieve growth at scale. A key aspect of
\nimproving the speed, timeliness, costs, and accuracy of
\ntrials is implementing a clinical trial management system
\n(CTMS) that is optimized for business operations. Heron
\nTherapeutics, a biotech company with three commercial
\nproducts and over 10 studies running in various stages
\nat any given time, develops therapies for oncology and
\nacute care.\n<\/p>\n

\nHeron applies its innovative science and technologies to
\ndevelop patient-focused treatments. The company has implemented the Veeva RIM, Veeva Quality, and several applications within Veeva Clinical Operations \u2014 including Veeva CTMS<\/a>. With over 50
\nactive sites and counting, Heron\u2019s implementation of Veeva CTMS enables proactive trial management,
\noperational efficiency, and improved collaboration, among other advantages.\n<\/p>\n

\"\"<\/p>\n

Drivers for implementing a new clinical trial management system<\/h2>\n

\nRealizing the need to speed trials, gain greater visibility, and improve study analytics, Heron implemented a CTMS
\nwith another provider in 2017, but the system was not user-friendly or intuitive, and it didn\u2019t easily integrate with
\nthe company\u2019s other clinical systems. The CTMS wasn\u2019t adopted by users.\n<\/p>\n

\nWhen Susan Stamford, Heron\u2019s executive director of clinical operations, joined the company in 2019, one of her
\nkey tasks was to replace the existing CTMS with a more modern system that better aligned with Heron\u2019s values,
\ngoals, strategies, and systems. \u201cI knew we needed a solution that could support our growth and that was in line
\nwith our other operational activities,\u201d said Stamford. \u201cOne of the most important criteria was having a single
\nsource of truth so we could easily pull data together in one place to reduce errors.\u201d\n<\/p>\n

\nHeron relied heavily on Word documents and Excel trackers that required multiple manual reviews for quality
\ncontrol. Based on prior experience, Heron\u2019s clinical leaders knew they had to digitize as many processes and
\nactivities as possible and focus on preparing the organization for change to drive the adoption of new technology.
\n\u201cI had a lot of sleepless nights thinking about CTMS implementation, especially when our prior solution was in
\nplace,\u201d said Stamford, who has worked in clinical operations for more than 25 years. \u201cThey stopped once we
\ndecided to implement Veeva and actually started the implementation.\u201d<\/p>\n

\n
\n